Nafamostat Mesylate Regulates Glycosylation to Alleviate Aristolochic Acid Induced Kidney Injury
Acute kidney injury (AKI) is a condition with a poor prognosis, exacerbated by the lack of effective therapeutic options and inadequately understood underlying mechanisms. Glycosylation, a post-translational modification of proteins, is essential for maintaining protein stability and function, and i...
Saved in:
| Main Authors: | Pei Xie, Huijun Liu, Xingli Huo, Junlong Chen, Yu Li, Yu Huang, Zongning Yin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Toxins |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6651/17/3/145 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of nafamostat mesilate for sepsis (EASNMS): study protocol for a multicenter randomized controlled trial
by: Hongyu Yang, et al.
Published: (2025-07-01) -
Research advances of protein N-glycosylation’s biological functions and analytical methods and its role in kidney disease
by: 任伟夫, et al.
Published: (2021-01-01) -
Are viral vector-mediated therapies compatible with aberrant glycosylation?
by: I.J.J. Muffels, et al.
Published: (2025-09-01) -
GlycoIP: an integrated platform for simultaneous and site-specific N/O-glycosylation analysis of human semen
by: Gaoshu Yan, et al.
Published: (2025-05-01) -
Research Progress on the Function Properties and Application of Glycosylated Proteins
by: Bincheng ZHANG, et al.
Published: (2025-09-01)